Valuation: APTOCROM Inc.

Market Cap 24.86B 18.62M 16.91M 15.63M 14.11M 26.64M 1.75B 27.57M 188M 74.46M 938M 69.85M 68.37M 2.97B P/E 2024
-2.12x
P/E 2025 -9.5x
Enterprise Value 7.66B 5.74M 5.21M 4.82M 4.35M 8.21M 539M 8.5M 57.93M 22.96M 289M 21.54M 21.08M 916M EV / Sales 2024
4.85x
EV / Sales 2025 3.87x
Free-Float
14.22%
Yield 2024 *
-
Yield 2025 -
1 day-0.79%
1 week+0.18%
Current month-6.59%
1 month-11.19%
3 months-3.64%
6 months-46.31%
Current year-67.14%
1 week 1,603
Extreme 1603
1,709
1 month 1,382
Extreme 1382
1,926
Current year 1,382
Extreme 1382
5,400
1 year 1,382
Extreme 1382
5,940
3 years 1,382
Extreme 1382
18,800
5 years 1,382
Extreme 1382
76,300
10 years 1,382
Extreme 1382
333,000
Manager TitleAgeSince
Chief Executive Officer 70 23/03/2022
Comptroller/Controller/Auditor 51 -
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 59 -
Director/Board Member 70 23/03/2022
Director/Board Member 63 10/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%+0.18%-70.45%-90.29% 18.74M
-0.82%+1.40%+39.64%+143.17% 1,286B
-1.12%+0.16%+44.21%+88.24% 688B
-0.16%+0.43%+26.76%+113.01% 521B
+1.14%+2.04%+43.06%+72.81% 386B
-2.23%-2.89%+55.47%+41.64% 364B
+1.27%+1.72%+30.01%+63.11% 302B
+0.37%+0.75%+3.71%+39.09% 287B
-0.72%-0.63%+37.29%+71.87% 252B
-0.30%-1.03%+34.04%+124.88% 208B
Average -0.34%+0.53%+24.37%+66.75% 429B
Weighted average by Cap. -0.47%+0.84%+36.97%+98.13%

Financials

2024 2025
Net sales 16.4B 12.28M 11.16M 10.31M 9.31M 17.57M 1.15B 18.19M 124M 49.13M 619M 46.09M 45.11M 1.96B 9.81B 7.35M 6.67M 6.17M 5.57M 10.51M 690M 10.88M 74.14M 29.38M 370M 27.56M 26.98M 1.17B
Net income -28.09B -21.04M -19.12M -17.66M -15.95M -30.11M -1.98B -31.17M -212M -84.16M -1.06B -78.95M -77.28M -3.36B -5.56B -4.16M -3.78M -3.5M -3.16M -5.96M -391M -6.17M -42.03M -16.65M -210M -15.62M -15.29M -665M
Net Debt -25.07B -18.77M -17.06M -15.76M -14.23M -26.86M -1.76B -27.81M -190M -75.09M -946M -70.45M -68.96M -3B -17.19B -12.88M -11.7M -10.81M -9.76M -18.42M -1.21B -19.07M -130M -51.5M -649M -48.32M -47.29M -2.06B
Projected Income Statement - Annual - APTOCROM Inc.
Logo APTOCROM Inc.
Aptocrom Inc, formerly AP Healthcare Inc, is a Korea-based company primarily engaged in the pharmaceutical business. The Company operates its business through three segments. The Pharmaceutical Business segment is mainly engaged in the distribution and sale of drugs such as digestive organs medicine, outer skin medicine, nutrient tonic alteration and antibiotics. The Insulation Business segment is mainly engaged in the production, design, manufacturing and construction of industrial insulation. The Rental Business segment is mainly engaged in the real estate business such as offices and laboratories. The Company sells its products in domestic and overseas markets.
Employees
11
Date Price Change Volume
16/11/26 ₩1,643.00 -0.79% 4,033
13/11/26 ₩1,656.00 +0.12% 1,097
12/11/26 ₩1,654.00 -0.06% 756
11/11/26 ₩1,655.00 +0.85% 149
10/11/26 ₩1,641.00 +0.06% 5,447
  1. Stock Market
  2. Stocks
  3. A109960 Stock